Indegene yesterday launched a new centre in Germany, expanding its client-focussed consulting and management team in the region, a company statement has said.
It stated that with this centre, the company is further strengthening its presence in Europe to help lifesciences companies fast-track digital transformation across the commercialisation value chain. The company’s local expert teams will work closely with clients in Germany and across Europe to provide consulting services and healthcare solutions.
Indegene already has a significant presence in Europe, with centres in the UK, Ireland and Switzerland. In 2019, Indegene acquired DT Associates, a consulting services company in the UK, supporting clients in the healthcare and lifesciences space. Indegene supports many leading lifesciences clients in the region in a variety of ways across the commercialisation value chain, it further mentioned.
Medicine spending in Germany is expected to rise from $64.6 billion in 2021 to $76-96 billion at a CAGR of 4.5-7.5 per cent (2022-2026), the statement added, the statement concluded.
website is featured